Cite
APA Citation
Kelley, R., Gane, E., Assenat, E., Siebler, J., Galle, P., Merle, P., Hourmand, I., Cleverly, A., Zhao, Y., Gueorguieva, I., Lahn, M., Faivre, S., Benhadji, K., & Giannelli, G. (2019). a Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma. Clinical and translational gastroenterology, 10(7), . http://access.bl.uk/ark:/81055/vdc_100122854896.0x00001f